New drug interaction study completed in 12 healthy volunteers
NCT ID NCT06846684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested whether a new drug called SB17170 changes how the body processes another drug, SB_MDZ. Twelve healthy adults took SB17170 by mouth and received SB_MDZ through an IV. Researchers measured drug levels in the blood to see if there is an interaction. The study is complete, but results are not yet available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SB17170 and SB_MDZ
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-DRUG INTERACTION (DDI) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Hospital
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new drug alter the fate of common medications?
- Tiny study checks if two drugs clash in the body
- New drug combo aims to shrink hard-to-treat tumors
- New drug safety check: how does JP-1366 mix with heart meds?
- Methotrexate drug interaction study aims to boost safety
- New antibiotic combo tested in healthy volunteers – no cure yet